Detecting Postoperative Recurrence in Crohn's Disease
Detection of Postoperative Recurrence of Crohn's Disease by Colonic Capsule-Endoscopy
1 other identifier
observational
70
1 country
4
Brief Summary
Up to ¾ of patients who have been diagnosed with Crohn's disease (CD) will have to undergo bowel resection during their lifetime despite modern medical therapies. Unfortunately, disease recurrence is common and endoscopic detection of recurring inflammation precedes clinical relapse. Endoscopic investigation is therefore recommended to manage these patients. This multi center, prospective study compares the conventional endoscopic method, ileo-colonoscopy to a new technique, i.e., colonic capsule endoscopy (CCE). CCE enables investigation of the small bowel and the large intestines by using a double-sided video camera with about 10 hours acquisition time. This study aims to evaluate the performance of CCE to detect postoperative recurrence of CD and detection rate of colonic and anastomotic recurrence is compared to ileo-colonoscopy. Proximal (small bowel) lesions are additionally recorded and impact on clinical management of the findings is accounted for. Moreover, safety aspects and influence of the findings on progress of the disease are monitored. All consecutive patients who are operated for CD in any of the participating study centers are eligible. Included are patients with segmental small bowel, ileocecal or segmental colonic resection. In some cases capsule retention has been reported at an average of 2-3% with CD patients at elevated risk. Therefore, patency capsule is performed before application of the video CCE to exclude bowel obstruction. Sample size estimation results in n = 70, requiring each 140 capsule endoscopes and 140 patency capsules for performance of postoperative screening (ca 4-8 weeks postoperatively) and detection of postoperative recurrence (ca 4-8 months postoperatively).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2009
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2009
CompletedFirst Posted
Study publicly available on registry
April 22, 2009
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMay 31, 2012
April 1, 2009
3.6 years
April 21, 2009
May 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection of postoperative recurrence of CD
Secondary Outcomes (4)
Therapeutic intervention due to detection of recurrent CD
Detection of small bowel lesions by CCE
Rate of bowel stenosis as detected by PC
Side effect of CCE and/or colonoscopy
Study Arms (1)
Postoperative patients
Patients with CD who recently underwent bowel resection
Interventions
Eligibility Criteria
All consecutive patients who are operated for CD in any of the participating study centers are eligible. Included are patients with segmental small bowel, ileocecal or segmental colonic resection. All patients have to give written informed consent before participating in the study.
You may qualify if:
- Segmental bowel resection for Crohn's disease
- Ileocecal resection
- Small bowel resection
- Segmental colonic resection
- Informed consent
- Age ≥ 18 years
You may not qualify if:
- Intestinal obstruction as suspected by anamnesis or clinical/technical investigation
- Dysphagia or ileus
- Non-passage of the intact 'Agile Patency Capsule' within 72 hours
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Klinikum der JW Goethe Universität Frankfurt
Frankfurt am Main, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Universitaetsklnikum Leipzig
Leipzig, Germany
Klinikum der Universität München - Campus Grosshadern
München, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joerg G Albert, MD
Johann Wolfgang Goethe University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 21, 2009
First Posted
April 22, 2009
Study Start
May 1, 2009
Primary Completion
December 1, 2012
Study Completion
December 1, 2013
Last Updated
May 31, 2012
Record last verified: 2009-04